Maintenance Therapy Without Steroids Feasible in Elderly Myeloma Patients

WEDNESDAY, March 24, 2021 -- Dose/schedule-adjusted lenalidomide-dexamethasone (Rd) followed by a maintenance regimen of lenalidomide 10 mg/day without dexamethasone (Rd-R) is feasible for older patients with multiple myeloma (MM), with survival...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news